5-(DIFLUOROMETHYL)PYRAZINE-2-CARBOXYLIC ACID, 95.0%, 250mg

Esponjas SurfACE LB (vial)

Methyl 2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetate, 95.0%, 250mg

2-methyl[1,3]oxazolo[5,4-d]pyrimidin-7(6H)-one, 95.0%, 5g

Methyl 2,5-dibromonicotinate, 95.0%, 500mg

[4-(methoxycarbonyl)-1H-pyrazol-1-yl]acetic acid, 500mg

6-(Benzyloxy)-2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96%, 250mg

N-Benzyloxycarbonyl-1,3-diaminopropane Hydrochloride>98.0%(T)5g

1-Benzofuran-3-carboxamide, 97%, 1g

4-Bromo-2-furoic acid, 95.0%, 1g

Objetivo de contraste de fase Plan PLPH 20x/0,40

5-Amino-1-boc-2-methylpiperidine, 98.0%, 250mg

Potassium 3-(tert-butyl)-1,2,4-oxadiazole-5-carboxylate, 95%, 250mg